Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Charles River Laboratories
Pharma
Charles River to help Navega produce gene therapy candidate
Charles River is back with another gene therapy pact—this time centered on an AAV candidate tackling chronic pain in rare disease patients.
Fraiser Kansteiner
Mar 14, 2024 9:50am
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Charles River Labs looks to keep growing with evolving industry
Jun 13, 2023 7:43am
China's reimbursement talks, Sun, GenScript—Fierce Pharma Asia
Jan 20, 2023 9:00am
CRL inks pact to help develop liver cancer gene therapy
Jan 18, 2023 2:45pm
Charles River cell therapy push powers on with latest expansion
Nov 8, 2022 9:45am
